Zenotech Laboratories Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Zenotech Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Jun 13, 2023
-15.7
TTM PE Ratio
Above industry Median
45
Price to Book Ratio
Above industry Median
4.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.6
RSI
RSI is mid-range
40.3
MFI
MFI is mid-range
41.4

Zenotech Laboratories Ltd shareholding Pattern

Promoter
68.8%
Public
30.2%
Promoter
68.8%
Public
30.2%
Promoter
68.8%
Public
30.2%
Promoter
68.8%
Public
30.2%
Promoter
68.8%
Public
30.2%
Promoter
68.8%
Public
30.2%

Zenotech Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
61.50
10Day EMA
62.00
12Day EMA
62.20
20Day EMA
63.00
26Day EMA
63.40
50Day EMA
64.70
100Day EMA
65.60
200Day EMA
64.40
5Day SMA
61.40
10Day SMA
62.00
20Day SMA
63.00
30Day SMA
64.40
50Day SMA
64.20
100Day SMA
68.00
150Day SMA
67.40
200Day SMA
64.80
Delivery & Volume
Resistance & Support
61.25
Pivot
Resistance
First Resistance
61.99
Second Resistance
62.75
Third Resistance
63.49
Support
First Support
60.49
Second support
59.75
Third Support
58.99
Relative Strength Index
40.27
Money Flow Index
41.36
MACD
-1.22
MACD Signal
-1.13
Average True Range
2.53
Average Directional Index
17.94
Rate of Change (21)
-11.96
Rate of Change (125)
-8.30
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Lyka Labs Ltd.
351.91
92.55
143.5
Venus Remedies Ltd.
396.8
194.95
429.6
Ambalal Sarabhai Enterprises Ltd.
-
-
-
Jenburkt Pharmaceuticals Ltd.
-
-
-
Kerala Ayurveda Ltd.
-
-
-
Zenotech Laboratories Ltd.
-
-
-
Fredun Pharmaceuticals Ltd.
-
-
-

Zenotech Laboratories Ltd Company background

Founded in: 1989
Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Companys injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.During financial year 200405, the Honble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. and resultant, the name of Company was changed to Zenotech Laboratories Ltd. with effect from August 10, 2004.M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006.Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015.The Company started production from its newly commissioned Depot Injectable facility in FY 201920. It renovated its Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their RD activities effective from July, 2021.
Read More

Zenotech Laboratories Ltd FAQs

You can easily buy Zenotech Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage